PHLPP2 and chronic myelogenous leukemia, BCR-ABL1 positive: Figure 1F shows AMPKα-pT172 levels increased when PHLPP2 was silenced in Molt4 (acute lymphocytic leukemia) and K562 (chronic myeloid leukemia) cell lines, and in epithelial cancer lines H522 (non-small cell lung cancer) and DLD1 (colorectal adenocarcinoma).